Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New Scale

Launched by SECOND AFFILIATED HOSPITAL OF XI'AN JIAOTONG UNIVERSITY · Feb 22, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to predict if patients with papillary thyroid cancer (PTC) will have cancer spread to their lymph nodes. Lymph nodes are small glands that can help fight infections, but when cancer spreads there, it can lead to complications. The study aims to gather information from over 1,000 patients who have had surgery for PTC from 2021 to 2023. Researchers will create a scoring scale that considers various factors to help decide if a patient should have additional surgery to remove lymph nodes. This could help avoid unnecessary surgery for some patients, reducing the risk of complications while ensuring those who need lymph node removal get the right treatment to prevent their cancer from coming back.

To be eligible for this trial, participants must be between 16 and 80 years old, diagnosed with papillary thyroid cancer, and able to communicate effectively. The study is currently recruiting participants, and everyone is welcome, regardless of gender. By joining, participants can contribute to developing a tool that may lead to more personalized and effective care for future patients with PTC.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Papillary thyroid cancer
• • Conscious and able to communicate normally
• • Age 16-80 years
• Exclusion Criteria:
• • Preoperative or postoperative pathology suggests other types of tumors, such as medullary carcinoma or undifferentiated carcinoma.
• • Less than 16 years of age